Maggot Debridement Market - Forecast(2021 - 2026)

Report Code: HCR 1384 Report Format: PDF + Excel (Delivery in 48 Hrs)

Maggot Debridement Market Overview

Maggot Debridement Market size is estimated to reach 16 million by 2026, growing at a CAGR of 9.5% during the forecast period 2021-2026. Maggot debridement therapy (MDT) is a kind of biotherapy including the injection of living, cleansed maggots (fly larvae) into the non-healing skin and delicate tissue injuries of a human or animal with the intention of cleaning out the necrotic (dead) tissue within an injury ( debridement ) and sanitization. The increasing predominance of diabetes is set to drive the Maggot Debridement Market owing to extended diabetes resulting in diabetic foot ulcers needing maggot debridement therapy. Autolytic debridement is a traditional technique, frequently utilized for patients who are unable to bear greater aggressive kinds of debridement. Suitable use of the dampness absorbent dressing and safeguard of the peri-wound skin while utilizing autolytic debridement is necessary. While specialists support maggot debridement technique (MDT) as a desperate remedial treatment when traditional approaches for injury bed arrangement are futile or when surgery is not possible owing to the presence of comorbid conditions or other considerations for the elimination of necrotic tissue, autolytic debridement results in relaxation of necrotic tissue. Maggot debridement therapy typically includes the use of sterile Lucilia sericata (common green bottle fly) larvae to a non-healing injury to advance treatment and reduce infection. Assumptions have been made from some investigations that maggot excretions/secretions lessen biofilm formation and this may offer a novel treatment for biofilm formation on contaminated biomaterials. This effect has been termed biofilm inhibition. Maggot debridement is primarily utilized in the healing of incessant injuries like venous leg ulcers and pressure ulcers which is set to propel the growth of the Maggot Debridement Market during the forecast period 2021-2026. This represents the Maggot Debridement Industry Outlook.

Maggot Debridement Market Report Coverage

The report: Maggot Debridement Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Maggot Debridement Market.

By Administration Type: Biobags, Loose Larva.
By Application: Acute Wounds (Burn Wounds, Surgical & Traumatic Wounds). Chronic Wounds (Pressure Ulcers, Diabetic Foot Ulcers, Venous Leg Ulcers, Others).
By End Use: Hospitals, Wound Care Centers, Clinics, Others.
By Geography: North America (U.S, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Rest of South America) and Rest Of The World (Middle East, Africa).

Key Takeaways

  • Geographically, North America Maggot Debridement Market accounted for the highest revenue share in 2020 and it is poised to dominate the market over the period 2021-2026 owing to the boost in the occurrences of athletic and other sporting injuries, venous leg ulcers, and the rising count of road accidents in the North American region.
  • Maggot Debridement Market growth is being driven by the growing count of burn cases and venous leg ulcers, increasing predominance of incessant ailments like diabetes causing diabetic foot ulcers, and the heightening investment in Research and Development (R&D). However, the soaring cost of bagged maggots owing to their manufacturing process being greatly labor-exhaustive and the cost of therapy with bagged maggots being significantly greater owing to the utilization of two or more times as many larvae and two or more times, as many applications, on an average to bring about an identical debridement as free-range maggots is one of the major factors hampering the growth of Maggot Debridement Market. 
  • Maggot Debridement Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Maggot Debridement Market report. 

 Maggot Debridement Market: Market Share (%) by Region, 2020

For More Details on This Report - Request for Sample

Maggot Debridement Market Segment Analysis – By Administration Type

The Maggot Debridement Market based on Administration Type can be further segmented into Biobags and Loose Larva. The Biobags Segment held the largest market share in 2020. This growth is owing to expanding predominance of incessant injuries like venous leg ulcers worldwide. Biobags are comparatively more secure for utilization. In 2015, BioMonde declared the kick-off of Biobag, a bio surgical medical device for the debridement of different injuries like pressure ulcers, neuropathic ulcers, venous stasis ulcers and non-healing dreadful or surgical injuries. Biobag is the earliest contained bio surgical dressing cleared by the Food and Drug Administration (FDA). Furthermore, the Biobags segment is estimated to grow with the fastest CAGR of 10.7% during the forecast period 2021-2026 owing to the boost in the count of surgeries globally and the lack of safety of loose larva.

Maggot Debridement Market Segment Analysis – By Application

The Maggot Debridement Market based on the application can be further segmented into Acute Wounds (Burn Wounds, Surgical & Traumatic Wounds). Chronic Wounds (Pressure Ulcers, Diabetic Foot Ulcers, Venous Leg Ulcers, Others). The Chronic Wounds Segment held the largest market share in 2020. This growth is owing to a boost in incessant ailments like venous leg ulcers, pressure ulcers and diabetes in communities globally resulting in diabetic foot ulcers. Pressure ulcers are termed as bed-sores and typically happen in the ankles, tips and tail-bones. Pressure ulcers are mostly seen in the elderly. As per World Health Organization (WHO), approximately 180,000 deaths occur each year owing to burns, the enormous bulk happening in low- and middle- income nations. The Acute Wounds segment is estimated to grow with the fastest CAGR of 9.9% during the forecast period 2021-2026 owing to the increased count of burn injuries and fire-associated traumas worldwide. 

Maggot Debridement Market Segment Analysis – By Geography

The Maggot Debridement Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America and Rest of the World. North America (Maggot Debridement Market) held the largest share with 28% of the overall market in 2020. The growth of this region is owing to the increased count of incessant ailments like venous leg ulcers,well-established healthcare industry, supportive reimbursement policies and the presence of key players like Monarch Labs in the region. As per World Health Organization (WHO), around 1.3 million people lose their lives every year owing to road traffic crashes. The Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2021-2026. This growth is owing to factors like boost in count of wound-dressings owing to an increased number of injuries with growing motorization in countries like India which is fuelling the progress of the Maggot Debridement Market in the Asia-Pacific region.

Maggot Debridement Market - Drivers

Global Prevalence Of Incessant Ailments Like Venous Leg Ulcers Is Projected To Drive The Growth Of Maggot Debridement Market:

As per National Health Service (NHS), venous leg ulcers are the most typical kind of leg ulcers, responsible for over 90% of total cases. Venous leg ulcers may bring about pain, physical and mental pressure, public exclusion and despair. These ulcers take nearly 12 weeks to cure and the earliest treatment to attempt is compression bandages. In an effort to enhance the curing procedure, it is considered that eliminating necrotic tissue through techniques like maggot debridement from the top of the injury can fasten the curing process. The growing number of venous leg ulcers in communities worldwide is resulting in the increasing application of maggot debridement which is fuelling the growth of the Maggot Debridement Market during the forecast period 2021-2026.

Innovations Are Expected To Boost The Demand Of Maggot Debridement:

Maggot enzymes decrease inflammation, remove bacteria, clot blood and provoke healing responses which are all beneficial while attempting to cleanse necrotic tissues, incessant injuries and infections. Aurase® is a product under examination including a hydrogel planned to be utilized in injury debridement to assist in elimination of necrotic (dead) or diseased tissue. It includes an enzyme detached and cloned from medical maggots. Some advantages include rise in wound curing, decreased contaminations and it finds application in medical treatment. These kinds of innovations are driving the growth of the Maggot Debridement Market during the forecast period 2021-2026.

Maggot Debridement Market – Challenges

Side-Effects And Disadvantages Of Maggots Debridement Therapy Are Hampering The Growth Of Maggots Debridement Market:

Maggots Debridement Therapy (MDT) has numerous side effects and hazards ranging from localized tissue discomfort to contamination to the vision of maggots breaking away. The major disadvantages of MDT are aesthetic and injury pain/pruritus, and the later can be healed with analgesics. Infrequently, patients can possess influenza-like symptoms, transient pyrexia, or allergic reactions. These issues are challenging the growth of Maggots Debridement Market.

Maggot Debridement Market - Landscape

Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Maggot Debridement Market. Key companies of this market include: 

  • BioMonde
  • Monarch Labs
  • Smith & Nephew
  • B. Braun Melsungen AG
  • Molnlycke Healthcare
  • ConvaTec
  • Lohmann & Rauscher
  • Arobella Medical
  • LLC Integra Lifesciences
  • Advancis Medical

Acquisitions/Product Launches:

  • In May 2021, Smith+Nephew introduced ARIA Home PT, a remote physical therapy solution as part of the ARIA suite of solutions. This gives patient fulfillment and enhanced engagement by permitting patients to perform physical therapy at home, on-demand, and without utilizing wearable sensors.
  • In October 2020, Molnlycke introduced novel skin-friendly Biogel® surgical gloves to decrease the possibility of allergic contact dermatitis for surgeons and nurses as part of its World Handwashing Day commemoration.

Related Reports

Wound Debridement Market

Report Code: HCR 71401

Wound Debridement Devices Market

Report Code: HCR 64560

For more Lifesciences and Healthcare Market reports, please click here

1. Maggot Debridement Market - Overview
    1.1 Definitions and Scope
2. Maggot Debridement Market - Executive Summary
    2.1 Market Revenue, Market Size and Key Trends
    2.2 Key trends by Administration Type
    2.3 Key trends by Application
    2.4 Key trends by End Use
    2.5 Key trends by Geography
3. Maggot Debridement Market - Comparative Analysis
    3.1 Company Benchmarking – Key Companies
    3.2 Financial Analysis– Key Companies
    3.3 Market Share Analysis– Key Companies
    3.4 Patent Analysis
    3.5 Pricing Analysis- Average Selling Price
4. Maggot Debridement Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Maggot Debridement Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing Business Index
    5.3 Case Studies of Successful Ventures
6. Maggot Debridement Market - Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Maggot Debridement Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Maggot Debridement Market – By Administration Type (Market Size –$Million/$Billion)
    8.1 Biobags
    8.2 Loose Larva
9. Maggot Debridement Market – By Application (Market Size –$Million/$Billion)
    9.1 Acute Wounds
        9.1.1 Burn Wounds
        9.1.2 Surgical & Traumatic Wounds
    9.2 Chronic Wounds
        9.2.1 Pressure Ulcers
        9.2.2 Diabetic Foot Ulcers
        9.2.3 Venous Leg Ulcers
        9.2.4 Others
10. Maggot Debridement Market – By End Use (Market Size –$Million/$Billion)
    10.1 Hospitals
    10.2 Wound Care Centers
    10.3 Clinics
    10.4 Others
11. Maggot Debridement Market - By Geography (Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 U.K.
        11.2.2 Germany
        11.2.3 France
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia-Pacific
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Rest of South America
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. Maggot Debridement Market - Entropy
13. Maggot Debridement Market – Industry/Segment Competition Landscape Premium 
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Competition Matrix
        13.1.5 Best Practices for Companies
14. Maggot Debridement Market – Key Company List by Country Premium Premium
15. Maggot Debridement Market Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.